60 Degrees Pharma Withdraws Study Application for COVID Drug 60 Degrees Pharma Withdraws Study Application for COVID Drug

60 Degrees Pharmaceuticals said on Monday it has withdrawn an application to the FDA for a midstage study testing its experimental drug for COVID-19.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news